Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bausch Health Cos Inc. (BHC : NYSE)

• Company Description    Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. Number of Employees: 20,700

• Price / Volume Information    Yesterday's Closing Price: $6.65 Daily Weekly Monthly 20 Day Moving Average: 2,368,461 shares Shares Outstanding: 370.85 (millions) Market Capitalization: $2,466.18 (millions) Beta: 0.47 52 Week High: $9.49 52 Week Low: $4.25 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.92% 7.04% 12 Week -20.26% -23.57% Year To Date -17.49% -27.88%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2150 ST. ELZEAR BLVD. WEST - LAVAL,A8 H7L 4A8 CAN ph: 514-744-6792 fax: 514-744-6272 ir@bauschhealth.com http://www.bauschhealth.com

• General Corporate Information    Officers Thomas J. Appio - Chief Executive Officer and Director John A. Paulson - Chairperson of the Board and Director Jean-Jacques Charhon - Executive Vice President; Chief Financial Officer John S. Barresi - Senior Vice President; Controller and Chief Accoun Christian A. Garcia - Director Peer Information Bausch Health Cos Inc. (BGMR) Bausch Health Cos Inc. (BBIO) Bausch Health Cos Inc. (IPAH) Bausch Health Cos Inc. (BRL) Bausch Health Cos Inc. (BHC) Bausch Health Cos Inc. (AKRXQ) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-GENERIC DRG Sector: Medical CUSIP: 071734107 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/18/26 Share - Related Items Shares Outstanding: 370.85 Most Recent Split Date: 10.00 (2.00:1) Beta: 0.47 Market Capitalization: $2,466.18 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $1.23 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.85 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/18/26

• Fundamental Ratios P/E Current FY Estimate: 1.73 Trailing 12 Months: 1.75 PEG Ratio: - Price Ratios Price/Book: 6.93 Price/Cash Flow: 0.86 Price / Sales: 0.25 EPS Growth vs. Year Ago Period: 3.57% vs. Previous Quarter: 28.89% Sales Growth vs. Year Ago Period: 6.81% vs. Previous Quarter: 5.97% ROE 09/30/25 - -9,620.34 06/30/25 - -852.36 03/31/25 - -540.45 ROA 09/30/25 - 5.30 06/30/25 - 5.25 03/31/25 - 5.26 Current Ratio 09/30/25 - 1.30 06/30/25 - 1.31 03/31/25 - 1.35 Quick Ratio 09/30/25 - 0.97 06/30/25 - 0.98 03/31/25 - 0.97 Operating Margin 09/30/25 - 14.15 06/30/25 - 14.20 03/31/25 - 14.31 Net Margin 09/30/25 - 3.61 06/30/25 - 0.99 03/31/25 - -0.41 Pre-Tax Margin 09/30/25 - 5.18 06/30/25 - 2.85 03/31/25 - 1.94 Book Value 09/30/25 - 0.96 06/30/25 - 0.40 03/31/25 - -0.65 Inventory Turnover 09/30/25 - 1.82 06/30/25 - 1.77 03/31/25 - 1.76 Debt-to-Equity 09/30/25 - 57.48 06/30/25 - 141.90 03/31/25 - - Debt-to-Capital 09/30/25 - 98.29 06/30/25 - 99.30 03/31/25 - -

Powered by Zacks Investment Research ©